BECTON DICKINSON AND CO (BDX)

BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-first health...

Becton Dickinson to Pay $175 Million to Settle SEC Probe

Becton, Dickinson & Co. has agreed to a $175 million fine over Securities and Exchange Commission claims it repeatedly misled investors about one of its most important products.

BD Resolves Previously Disclosed SEC Investigation

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement: BD has...

Thursday's session: top gainers and losers in the S&P500 index

Top movers analysis one hour before the close of the markets of S&P500 on 2024-12-12: top gainers and losers in today's session.

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors

Carl Hull to Retire as Executive Chairman

First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities

/PRNewswire/ -- A first of its kind Human Papillomavirus (HPV) self-collection screening pilot program aimed at improving cervical cancer screening in...

BD to Present at the 7th Annual Evercore ISI HealthCONx Conference

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 7th...

YieldBoost Becton, Dickinson To 11% Using Options

See Which Of The Latest 13F Filers Holds Becton, Dickinson & Co

BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

Strong Growth and Margin Execution Drives Performance in Quarter Q4 revenue of $5.4 billion increased 6.9% as reported, 7.4% currency-neutral and 6.2% organic...

BD Board Increases Dividend for 53rd Consecutive Year

/PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.04 per common share, an...

BD Launches Enhanced Intraosseous System, Enabling Vascular Access in Seconds for Critical Care Situations

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched the new BD® Intraosseous Vascular...

BD Named Among the 100 Best Corporate Citizens of 2024

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named as one of the...

O'Reilly Automotive Moves Up In Market Cap Rank, Passing Becton, Dickinson

BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial launch of the first...

BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial...

Becton Dickinson Hernia-Mesh Settlements Will Exceed $1 Billion

Becton Dickinson & Co. will pay more than $1 billion to resolve more than 38,000 lawsuits alleging medical patients suffered damaged organs from surgical mesh improperly used to treat hernias, according to people familiar with the deal who weren’t authorized to speak publicly.

Becton Dickinson Settles Vast Majority of Hernia-Mesh Lawsuits

Becton Dickinson & Co. has agreed to settle the vast majority of the thousands of lawsuits claiming hernia patients were harmed by improper surgical mesh made by units of the medical technology giant, ending one of the largest current mass-tort litigations in the US.

BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has reached an agreement to...

New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its...

BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™...

BD Completes Acquisition of Critical Care from Edwards Lifesciences

Expands BD's portfolio of smart connected care solutions with leading monitoring technologies, including advanced AI-enabled clinical decision tools...

BD Celebrates 75 years of U.S. Manufacturing Excellence in Nebraska

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today celebrated the 75th anniversary of its...

S&P 500 Analyst Moves: BDX

BDX November 15th Options Begin Trading

BD Names Michael Feld as President of Life Sciences Segment

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michael Feld has been named...

BD to Present at Wells Fargo 2024 Healthcare Conference

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells...

The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024

Explore the best dividend payouts from leading companies for sustainable, steady and growing income streams.